Table 1.
Virus Yield | |||
---|---|---|---|
Cell | Virus | Untreated (TICD50/ml) |
IFN-treated (TICD50/ml) |
CONkd | WT | 1.4 ± 0.3 × 106 | 1.3 ± 0.2 × 105 |
Vko | 1.0 ± 0.1 × 106 | 6.6 ± 1.7 × 104 | |
Cko | 2.8 ± 0.1 × 104 | 2.6 ± 0.6 × 103 | |
PKRkd | WT | 1.0 ± 1.0 × 106 | 1.4 ± 0.1 × 105 |
Vko | 1.5 ± 0.3 × 106 | 1.1 ± 0.1 × 105 | |
Cko | 8.0 ± 0.8 × 104 | 3.5 ± 0.3 × 103 | |
ADAR1kd | WT | 1.0 ± 0.1 × 106 | 1.4 ± 0.1 × 105 |
Vko | 4.3 ± 0.1 × 105 | 2.8 ± 0.2 × 104 | |
Cko | 2.0 ± 0.5 × 104 | 6.8 ± 0.2 × 102 |
Virus yields were measured with the Moraten parental strain and mutants deficient in the expression of either V protien (Vko) or C protein (Cko) in puromycin-resistant control knockdown cells (CONKD), ADAR1 stable knockdown (ADAR1KD) and PKR stable knockdown (PKRKD) HeLa cell clones either untreated or pretreated with 1000 units/mL IFNβ prior to infection. Yields were determined by 50% TICD50 titation on Vero cells according to the Spearman-Karber method (Devaux 2008, Karber 1931). Results are means and standard errors (n=3).